date:May 05, 2012
Bright Food will pay 720m to acquire 60% controlling stake in Weetabix from UK private equity firm Lion Capital. This deal values Weetabix at 1.2bn, including debt. Lion Capital and Weetabix management will hold a 40% stake in Weetabix.
The transaction, which is subject to Chinese regulatory approval, is expected to be completed in the second half of 2012.
Bright Foods was advised by banking group Rothschild and lawyers Linklaters over the deal.
If this acquisition is closed, it would mark Brigh